Company Meetings - Aptus Pharma Ltd.
Search Company
You can view Income Statement for the last 5 years.
ISIN No INE112B01013 52Wk High (Rs.) 17 BV (Rs.) 0.11 FV (Rs.) 10.00
Bookclosure 27/09/2025 52Wk Low (Rs.) 8 EPS (Rs.) 0.44 P/E (X) 21.86
Mkt Cap. (Rs. Cr.) 7.64 P/BV (X) 0.00 Div Yield (%) 0.00 Mkt Lot 1
Standalone
(Rs. in Crs.)
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]5.710.580.000.000.00
Total Operating Revenues5.710.580.000.000.00
      
Other Income0.350.000.000.000.08
Total Revenue6.060.580.000.000.08
      
EXPENSES     
Purchase Of Stock-In Trade5.460.000.000.000.00
Employee Benefit Expenses0.030.030.060.060.06
Other Expenses0.210.210.110.220.09
Total Expenses5.710.230.170.280.15
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax0.350.35-0.17-0.28-0.07
      
Profit/Loss Before Tax0.350.35-0.17-0.28-0.07
      
Tax Expenses-Continued Operations     
Profit/Loss After Tax And Before ExtraOrdinary Items0.350.35-0.17-0.28-0.07
      
Profit/Loss From Continuing Operations0.350.35-0.17-0.28-0.07
      
Profit/Loss For The Period0.350.35-0.17-0.28-0.07
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)0.440.44-0.22-0.35-0.09
Diluted EPS (Rs.)0.440.44-0.22-0.35-0.09